Abramson Cancer Center at University of Pennsylvania — Philadelphia, Pennsylvania

Public research footprint of Abramson Cancer Center at University of Pennsylvania, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Breast Cancer · Cardiotoxicity · Cancer · Melanoma

Recently updated registry entries

NCT03143270 — A Study to Test the Safety and Feasibility of Nivolumab With Drug Eluting Bead… (Completed)
NCT03179917 — Pembrolizumab and Involved Site Radiation Therapy for Early Stage Relapsed or Primary… (Active Not Recruiting)
NCT06770855 — Consolidative Metastasis and Primary Directed Therapy (MPDT) for Renal Cell Carcinoma… (Not Yet Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Abramson Cancer Center at University of Pennsylvania?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.